NCT06680336

Brief Summary

RECOVER is a Proof-of-Concept study on cognitive functioning following a longitudinal design with three measurements (during the acute- and post-acute phases of a stroke and a 3-month follow-up) and two equally-sized stroke patient groups: a post-stroke delirium(PSD), and a non-PSD group (control group). Cognitive functioning will be assessed using a multi-component neuropsychological assessment and tasked-based functional MRI (introducing a modified working memory task).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2023

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 8, 2024

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 8, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

November 8, 2024

Status Verified

July 1, 2024

Enrollment Period

1.7 years

First QC Date

July 8, 2024

Last Update Submit

November 6, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Global post-stroke cognitive functioning

    The primary endpoint will be a between-group comparison of the cognitive outcome, defined as global post-stroke cognitive functioning, at 3 months follow-up (S3), using multimodal data generated from the neuropsychological assessment and tasked-based fMRI.

    90 days

Secondary Outcomes (2)

  • Domain specific post-stroke cognitive functioning

    90 days

  • Prediction of global post-stroke cognitive outcome

    5 - 90 days

Study Arms (2)

Post-stroke Delirium

OTHER

Assessment of cognitive functioning using a multi-component neuropsychological assessment and tasked-based functional MRI (introducing a modified working memory task) at three time points S1, S2, S3.

Diagnostic Test: Mulit-componant neuropsychological assessmentDiagnostic Test: Multimodal MRI

Non-post-stroke Delirium

OTHER

Assessment of cognitive functioning using a multi-component neuropsychological assessment and tasked-based functional MRI (introducing a modified working memory task) at three time points S1, S2, S3.

Diagnostic Test: Mulit-componant neuropsychological assessmentDiagnostic Test: Multimodal MRI

Interventions

Multi-component cognitive assessment including following domains: attention \& information speed, executive functioning, verbal memory, language, visuospatial-construction and orientation.

Non-post-stroke DeliriumPost-stroke Delirium
Multimodal MRIDIAGNOSTIC_TEST

Structural MRI (e.g., MPRAGE, DTI) and functional MRI (introducing a modified working memory task for stroke patients)

Non-post-stroke DeliriumPost-stroke Delirium

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 60 years
  • Ischemic stroke: Stroke Onset ≤ 96h, hospital admission ≤ 48h
  • NIHSS ≥ 1
  • Informed consent by patient or legal guardian

You may not qualify if:

  • Aphasia
  • Pre-existing conditions such as Dementia, psychiatric disorders (e.g., Depression, Schizophrenia)
  • MRI contraindication such as certain metal implants
  • Reduced consciousness, defined as Glasgow Coma Scale (GCS) ≤ 8
  • Delirium onset before study enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Neurology, University Hospital Tuebingen

Tübingen, Germany

RECRUITING

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Longitudinal study with 3 measurements (S1, S2, S3) and two groups of stroke patients (post-stroke-delirium (PSD) patients, non PSD patients)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2024

First Posted

November 8, 2024

Study Start

December 1, 2023

Primary Completion

August 1, 2025

Study Completion

November 1, 2025

Last Updated

November 8, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations